|View printer-friendly version|
|July 25, 2000 3:27 p.m.|
|Teva Pharmaceutical Industries Ltd Announces tentative FDA Approval of Nifedipine XL, 30 mg and 60 mg|
Jerusalem, Israel, July 25, 2000 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the FDA awarded tentative U.S. approval for Nifedipine XL, 30mg and 60mg. These approvals were issued to Biovail Corporation. These products are included in the exclusive US marketing agreement between Teva and Biovail relating to Biovail's line of generic sustained release products.